Receptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: Improved immunogene approach

Cancer Gene Therapy

Volumn 5, Issue 6, 1998, Pages 357-364

  Chen, Jiabing ^a   Gamou, Shinobu ^a   Takayanagi, Atsushi ^a   Ohtake, Yuichiro ^a   Ohtsubo, Masafumi ^a   Shimizu, Nobuyoshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Anti epidermal growth factor receptor antibody; Endocytosis; Fab; Immunogene; Suicide gene

Indexed keywords

BETA GALACTOSIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GANCICLOVIR; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE;

ANIMAL; ARTICLE; CELL CULTURE; CELL NUCLEUS; CHEMISTRY; ENZYMOLOGY; GENE TARGETING; GENE TRANSFER; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; REPORTER GENE; TIME;

ANIMALS; ANTIBODIES, MONOCLONAL; BETA-GALACTOSIDASE; CELL NUCLEUS; GANCICLOVIR; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MICE; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIMPLEXVIRUS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032199731     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Chen J, Gamou S, Takayanagi A, et al. A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 1994;338:167-169.
2. Shimizu N, Chen J, Gamou S, et al. Immunogene approach toward cancer gene therapy using epidermal growth factor receptor-mediated gene delivery. Cancer Gene Ther. 1996;3:113-120.
3. Shimizu N, Chen J, Takayanagi A, et al. Use of growth factor receptor-mediated endocytosis for therapeutic gene delivery: immunogene approach. Cell Pharmacol AIDS Sci. 1996;3:263-267.
4. Buschle M, Gotten M, Kirlappos H, et al. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther. 1995;6:753-761.
5. Foster BJ, Kern JA. HER2-targeted gene therapy. Hum Gene Ther. 1997;8:719-727.
6. 2 fragments and the effect of conjugated methotrexate on tumor growth in vivo. Cancer Immunol Immunother. 1985;19:211-214.
7. Sung C, Dedrick RL, Hall WA, et al. The spatial distribution of immunotoxins in solid tumors: Assessment by quantitative autoradiography. Cancer Res. 1993;53:2092-2099.
8. Gamou S, Hirai M, Rikimaru K, et al. Biosynthesis of the epidermal growth factor receptor in human squamous cell carcinoma lines: Secretion of the truncated receptor is not common to epidermal growth factor receptor-hyperproducing cells. Cell Struct Funct. 1988;13:25-38.
9. Behzadian MA, Shimizu N. Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor. Cell Struct Funct. 1985;10:219-232.
10. Coding JW. Production and application of monoclonal antibodies in cell biology, biochemistry, and immunology. In: Goding JW, ed. Monoclonal Antibodies: Principles and Practice. New York: Academic Press; 1983:118-122.
11. Gamou S, Shimosato Y, Shimizu N. Regulation of the epidermal growth factor receptor gene expression in a morphological variant isolated from an epidermal growth factor receptor-deficient small cell lung carcinoma cell line. Cell Growth Differ. 1990;1:351-359.
12. Fukuyama R, Ichijoh Y, Minoshima S, et al. Regional localization of the hepatocyte growth factor (HGF) gene to human chromosome 7 band q21.1. Genomics. 1991;11: 410-415.
13. Wang Y-M, Minoshima S, Shimizu N. Precise mapping of the EGF receptor gene on the human chromosome 7p12 using an improved FISH technique. Jpn J Human Genet. 1993;38:399-406.
14. Uchida T, Pappenheimer AM, Jr, Greany R. Diphtheria toxin and related proteins: Isolation and properties of mutant proteins serologically related to diphtheria toxin. J Biol Chem. 1973;248:3838-3844.
15. Yamamoto T, Kamata N, Kawano H, et al. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res. 1986;46:414-416.
16. Ozawa S, Ueda M, Ando N, et al. Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor, Int J Cancer. 1989;43:152-157.
17. Shimizu N. Epidermal growth factor receptors in lung cancer. In: Bernai SE, Hesketh PJ, eds. Lung Cancer Differentiation: Implications for Diagnosis and Treatment. New York: Marcel Dekker; 1992:137-158.
18. Van der Geer P, Hunter T, Lindberg RA. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol. 1994;10:251-337.
19. Wagner E, Plank C, Zatloukal K, et al. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA. 1992;89:7934-7938.
20. Curiel DT, Wagner E, Cotten M, et al. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther. 1992;3:147-154.
21. Wu GY, Zhan P, Sze LL, et al. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J Biol Chem. 1994;269:11542-11546.
22. Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci. 1994;19:459-463.
23. Baulida J, Kraus MH, Alimandi M, et al. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem. 1996;271:5251-5257.
24. HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol. 1989;9:1165-1172.
25. Cotten M, Wagner E, Zatloukal K, et al. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci USA. 1992;89:6094-6098.
26. Cristiano RJ, Smith LC, Woo SLC. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci USA. 1993;90:2122-2126.
27. Plank C, Oberhauser B, Mechtler K, et al. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem. 1994; 269:12918-12924.
28. Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 1995;270:18997-19007.
29. Bi WL, Parysek LM, Warnick R, et al. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther. 1993;4:725-731.
30. Fukuyama R, Shimizu N. Detection of epidermal growth factor receptors and E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn J Cancer Res. 1991;82:8-11.
31. Cristiano RJ, Curiel DT. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther. 1996;3:49-57.